Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3264)
All Articles published online
|
Jun 15, 2004 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang S, Ding YB, Chen GY, Xia JG, Wu ZY. Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma. World J Gastroenterol 2004; 10(12): 1815-1818 [PMID: 15188513 DOI: 10.3748/wjg.v10.i12.1815] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i12/1815.htm |
| Number | Citing Articles |
| 1 |
Céline Bourgne, Alexandre Janel, Juliette Berger, Chantal Rapatel, Olivier Tournilhac, Eric Hermet, Agnès Guerci, Frédérique Lioret, Aurélie Briançon, Mahchid Bamdad, Nathalie Boiret-Dupré, Marc G. Berger. Phosphorylation of spleen tyrosine kinase at tyrosine 348 (pSyk348) may be a marker of advanced phase of Chronic Myeloid Leukemia (CML). Leukemia Research 2015; 39(3): 329 doi: 10.1016/j.leukres.2014.11.014
|
| 2 |
E. Papazoglou, Z.Y. Huang, C. Sunkari, J. Uitto. The role of Syk kinase in ultraviolet-mediated skin damage. British Journal of Dermatology 2011; 165(1): 69 doi: 10.1111/j.1365-2133.2011.10309.x
|
| 3 |
Zuli Yang, Lijun Huo, Hao Chen, Beibei Ni, Jun Xiang, Liang Kang, Lei Wang, Junsheng Peng, Yunfei Yuan, Jianping Wang. Hypermethylation and prognostic implication of Syk gene in human colorectal cancer. Medical Oncology 2013; 30(2) doi: 10.1007/s12032-013-0586-8
|
| 4 |
Mariya O. Krisenko, Robert L. Geahlen. Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2015; 1853(1): 254 doi: 10.1016/j.bbamcr.2014.10.022
|
| 5 |
Vincent Denis, Nadège Cassagnard, Maguy Del Rio, Emmanuel Cornillot, Nicole Bec, Christian Larroque, Laura Jeanson, Marta Jarlier, Eve Combès, Bruno Robert, Céline Gongora, Pierre Martineau, Piona Dariavach, Yulia Komarova. Targeting the splicing isoforms of spleen tyrosine kinase affects the viability of colorectal cancer cells. PLOS ONE 2022; 17(9): e0274390 doi: 10.1371/journal.pone.0274390
|
| 6 |
Florentina Duta, Marina Ulanova, Daniel Seidel, Lakshmi Puttagunta, Sorin Musat-Marcu, Kevin S. Harrod, Alan D. Schreiber, Ulrich Steinhoff, A. Dean Befus. Differential expression of spleen tyrosine kinase Syk isoforms in tissues: effects of the microbial flora. Histochemistry and Cell Biology 2006; 126(4): 495 doi: 10.1007/s00418-006-0188-z
|
| 7 |
Zdenko Herceg, Paolo Boffetta. Environmental Factors, Genes, and the Development of Human Cancers. 2010; : 153 doi: 10.1007/978-1-4419-6752-7_7
|
| 8 |
Yinsheng Guo, Suli Huang, Yue Ma, Jin Zhang, Ying Wen, Li Zhou, Guanxiang Yuan, Jinquan Cheng. MiR-377 mediates the expression of Syk to attenuate atherosclerosis lesion development in ApoE−/− mice. Biomedicine & Pharmacotherapy 2019; 118: 109332 doi: 10.1016/j.biopha.2019.109332
|
| 9 |
Marina Ulanova, Alan D Schreiber, A Dean Befus. The Future of Antisense Oligonucleotides in the Treatment of Respiratory Diseases. BioDrugs 2006; 20(1): 1 doi: 10.2165/00063030-200620010-00001
|
| 10 |
Zhijuan Xiong, Chutian Xing, Ping Zhang, Yunlian Diao, Chenxi Guang, Ying Ying, Wei Zhang. Identification of a Novel Protein-Based Prognostic Model in Gastric Cancers. Biomedicines 2023; 11(3): 983 doi: 10.3390/biomedicines11030983
|
| 11 |
Christoph Hoeller, Christiane Thallinger, Barbara Pratscher, Malena D. Bister, Nikolaus Schicher, Robert Loewe, Elisabeth Heere-Ress, Florian Roka, Veronika Sexl, Hubert Pehamberger. The Non-Receptor-Associated Tyrosine Kinase Syk is a Regulator of Metastatic Behavior in Human Melanoma Cells. Journal of Investigative Dermatology 2005; 124(6): 1293 doi: 10.1111/j.0022-202X.2005.23685.x
|
| 12 |
Tracy Layton, Cristel Stalens, Felizza Gunderson, Steve Goodison, Steve Silletti. Syk Tyrosine Kinase Acts as a Pancreatic Adenocarcinoma Tumor Suppressor by Regulating Cellular Growth and Invasion. The American Journal of Pathology 2009; 175(6): 2625 doi: 10.2353/ajpath.2009.090543
|
| 13 |
Hironobu MURAKAMI, Toshihiro KUROIWA, Kazuhiko SUZUKI, Yasuo MIURA, Hiroshi SENTSUI. Analysis of Syk Expression in Bovine Lymphoma and Persistent Lymphocytosis Induced by Bovine Leukemia Virus. Journal of Veterinary Medical Science 2011; 73(1): 41 doi: 10.1292/jvms.10-0225
|
| 14 |
Yipeng Wang, Qiuju Yu, Ann H. Cho, Gaelle Rondeau, John Welsh, Eileen Adamson, Dan Mercola, Michael McClelland. Survey of Differentially Methylated Promoters in Prostate Cancer Cell Lines. Neoplasia 2005; 7(8): 748 doi: 10.1593/neo.05289
|
| 15 |
Hideaki Umeyama, Mitsuo Iwadate, Y-h. Taguchi. <i>In silico</i> Spleen Tyrosine Kinase Inhibitor Screening by ChooseLD. IPSJ Transactions on Bioinformatics 2015; 8(0): 14 doi: 10.2197/ipsjtbio.8.14
|
| 16 |
Aušra Imbrasaitė, Audronė V. Kalvelytė. The role of the tyrosine kinase Syk in retinoic acid-induced leukemic HL-60 cell differentiation. Biologija 2010; 56(1): 63 doi: 10.2478/v10054-010-0009-0
|
| 17 |
David I. Rodenhiser. Epigenetic contributions to cancer metastasis. Clinical & Experimental Metastasis 2009; 26(1): 5 doi: 10.1007/s10585-008-9166-2
|
| 18 |
Partha Biswas, Dipta Dey, Atikur Rahman, Md. Aminul Islam, Tasmina Ferdous Susmi, Md. Abu Kaium, Md. Nazmul Hasan, MD. Hasanur Rahman, Shafi Mahmud, Md. Abu Saleh, Priyanka Paul, Md Rezanur Rahman, Md. Al Al Saber, Hangyeul Song, Md. Ataur Rahman, Bonglee Kim. Analysis of SYK Gene as a Prognostic Biomarker and Suggested Potential Bioactive Phytochemicals as an Alternative Therapeutic Option for Colorectal Cancer: An In-Silico Pharmaco-Informatics Investigation. Journal of Personalized Medicine 2021; 11(9): 888 doi: 10.3390/jpm11090888
|
| 19 |
Peter J. Coopman, Susette C. Mueller. The Syk tyrosine kinase: A new negative regulator in tumor growth and progression. Cancer Letters 2006; 241(2): 159 doi: 10.1016/j.canlet.2005.11.004
|
| 20 |
Sachiko Inubushi, Motoko Nagano-Fujii, Kikumi Kitayama, Motofumi Tanaka, Chunying An, Hiroshi Yokozaki, Hirohei Yamamura, Hideko Nuriya, Michinori Kohara, Kiyonao Sada, Hak Hotta. Hepatitis C virus NS5A protein interacts with and negatively regulates the non-receptor protein tyrosine kinase Syk. Journal of General Virology 2008; 89(5): 1231 doi: 10.1099/vir.0.83510-0
|
| 21 |
So-Hyun Shin, Kwang Ho Lee, Baek-Hee Kim, Sun Lee, Hwan Seok Lee, Ja-June Jang, Gyeong Hoon Kang. Downregulation of spleen tyrosine kinase in hepatocellular carcinoma by promoter CpG island hypermethylation and its potential role in carcinogenesis. Laboratory Investigation 2014; 94(12): 1396 doi: 10.1038/labinvest.2014.118
|
| 22 |
Déborah Zyss, Philippe Montcourrier, Benjamin Vidal, Christelle Anguille, Fabrice Mérezègue, Alain Sahuquet, Paul H. Mangeat, Peter J. Coopman. The Syk Tyrosine Kinase Localizes to the Centrosomes and Negatively Affects Mitotic Progression. Cancer Research 2005; 65(23): 10872 doi: 10.1158/0008-5472.CAN-05-1270
|
| 23 |
Sumin Oh, Je Yeong Ko, Chaeun Oh, Kyung Hyun Yoo. Translational Research in Breast Cancer. Advances in Experimental Medicine and Biology 2017; 1026: 287 doi: 10.1007/978-981-10-6020-5_14
|
| 24 |
Thomas Wossning , Sebastian Herzog , Fabian Köhler , Sonja Meixlsperger , Yogesh Kulathu , Gerhard Mittler , Akihiro Abe , Uta Fuchs , Arndt Borkhardt , Hassan Jumaa . Deregulated Syk inhibits differentiation and induces growth factor–independent proliferation of pre–B cells . The Journal of Experimental Medicine 2006; 203(13): 2829 doi: 10.1084/jem.20060967
|
| 25 |
Satoru Ogane, Takeshi Onda, Nobuo Takano, Tetsuo Yajima, Takeshi Uchiyama, Takahiko Shibahara. Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma. International Journal of Cancer 2009; 124(11): 2651 doi: 10.1002/ijc.24237
|
| 26 |
Mauro Riccaboni, Ivana Bianchi, Paola Petrillo. Spleen tyrosine kinases: biology, therapeutic targets and drugs. Drug Discovery Today 2010; 15(13-14): 517 doi: 10.1016/j.drudis.2010.05.001
|
| 27 |
S Fruchon, S Kheirallah, T Al Saati, L Ysebaert, C Laurent, L Leseux, J J Fournié, G Laurent, C Bezombes. Involvement of the Syk–mTOR pathway in follicular lymphoma cell invasion and angiogenesis. Leukemia 2012; 26(4): 795 doi: 10.1038/leu.2011.248
|
| 28 |
Guillaume Fargier, Cyril Favard, Andrea Parmeggiani, Alain Sahuquet, Fabrice Mérezègue, Anne Morel, Marie Denis, Nicolas Molinari, Paul H. Mangeat, Peter J. Coopman, Philippe Montcourrier. Centrosomal targeting of Syk kinase is controlled by its catalytic activity and depends on microtubules and the dynein motor. The FASEB Journal 2013; 27(1): 109 doi: 10.1096/fj.11-202465
|
| 29 |
Lincan Duan, Lianhua Ye, Guangqiang Zhao, Zhengwei Wu, Congguo Jin, Xinyi Cai, Gaofeng Li. Serum spleen tyrosine kinase and vascular endothelial growth factor-C levels predict lymph node metastasis of oesophageal squamous cell carcinoma. European Journal of Cardio-Thoracic Surgery 2013; 43(3): e58 doi: 10.1093/ejcts/ezs637
|
| 30 |
Marina Ulanova, Florentina Duta, Lakshmi Puttagunta, Alan D Schreiber, A Dean Befus. Spleen tyrosine kinase (Syk) as a novel target for allergic asthma and rhinitis. Expert Opinion on Therapeutic Targets 2005; 9(5): 901 doi: 10.1517/14728222.9.5.901
|
| 31 |
Duen-Yi Huang, Shang-Te Lu, Yuan-Shen Chen, Ching-Yuan Cheng, Wan-Wan Lin. Epigenetic upregulation of spleen tyrosine kinase in cancer cells through p53-dependent downregulation of DNA methyltransferase. Experimental Cell Research 2023; 425(2): 113540 doi: 10.1016/j.yexcr.2023.113540
|
| 32 |
Sandy Giuliano, Mickaël Ohanna, Robert Ballotti, Corine Bertolotto. Advances in melanoma senescence and potential clinical application. Pigment Cell & Melanoma Research 2011; 24(2): 295 doi: 10.1111/j.1755-148X.2010.00820.x
|